The Evolution of Antibody-Drug Conjugates in Oncology - Have We Found Our Magic Bullet?
Yale Cancer Center via YouTube
MIT Sloan AI Adoption: Build a Playbook That Drives Real Business ROI
Free courses from frontend to fullstack and AI
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Join Dr. Ian Krop in this Yale Cancer Center Grand Rounds lecture exploring the fascinating evolution of Antibody-Drug Conjugates (ADCs) in cancer treatment and their potential as a "magic bullet" in oncology. Delve into the latest developments, mechanisms, and clinical applications of ADCs, examining how these targeted therapies have transformed cancer treatment approaches. Learn about the current state of ADC technology, its successes and challenges, and gain insights into future directions in this critical area of cancer therapeutics.
Syllabus
The Evolution of Antibody-Drug Conjugates in Oncology: Have we found our “Magic Bullet”? | Dr. Krop
Taught by
Yale Cancer Center